BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 27815594)

  • 1. WNK signalling pathways in blood pressure regulation.
    Murthy M; Kurz T; O'Shaughnessy KM
    Cell Mol Life Sci; 2017 Apr; 74(7):1261-1280. PubMed ID: 27815594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia.
    Glover M; O'Shaughnessy KM
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):876-84. PubMed ID: 23683032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
    Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
    Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex.
    Yang CL; Zhu X; Ellison DH
    J Clin Invest; 2007 Nov; 117(11):3403-11. PubMed ID: 17975670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.
    Richardson C; Rafiqi FH; Karlsson HK; Moleleki N; Vandewalle A; Campbell DG; Morrice NA; Alessi DR
    J Cell Sci; 2008 Mar; 121(Pt 5):675-84. PubMed ID: 18270262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters.
    Mercier-Zuber A; O'Shaughnessy KM
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):534-40. PubMed ID: 21610494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.
    Nishida H; Sohara E; Nomura N; Chiga M; Alessi DR; Rai T; Sasaki S; Uchida S
    Hypertension; 2012 Oct; 60(4):981-90. PubMed ID: 22949526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway.
    Wu A; Wolley M; Stowasser M
    J Hum Hypertens; 2019 Jul; 33(7):508-523. PubMed ID: 30723251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
    Yang CL; Angell J; Mitchell R; Ellison DH
    J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension.
    Brown A; Meor Azlan NF; Wu Z; Zhang J
    Acta Pharmacol Sin; 2021 Apr; 42(4):508-517. PubMed ID: 32724175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules.
    Grimm PR; Coleman R; Delpire E; Welling PA
    J Am Soc Nephrol; 2017 Sep; 28(9):2597-2606. PubMed ID: 28442491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
    Chávez-Canales M; Zhang C; Soukaseum C; Moreno E; Pacheco-Alvarez D; Vidal-Petiot E; Castañeda-Bueno M; Vázquez N; Rojas-Vega L; Meermeier NP; Rogers S; Jeunemaitre X; Yang CL; Ellison DH; Gamba G; Hadchouel J
    Hypertension; 2014 Nov; 64(5):1047-53. PubMed ID: 25113964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPAK isoforms and OSR1 regulate sodium-chloride co-transporters in a nephron-specific manner.
    Grimm PR; Taneja TK; Liu J; Coleman R; Chen YY; Delpire E; Wade JB; Welling PA
    J Biol Chem; 2012 Nov; 287(45):37673-90. PubMed ID: 22977235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation affecting the conserved acidic WNK1 motif causes inherited hyperkalemic hyperchloremic acidosis.
    Louis-Dit-Picard H; Kouranti I; Rafael C; Loisel-Ferreira I; Chavez-Canales M; Abdel-Khalek W; Argaiz ER; Baron S; Vacle S; Migeon T; Coleman R; Do Cruzeiro M; Hureaux M; Thurairajasingam N; Decramer S; Girerd X; O'Shaugnessy K; Mulatero P; Roussey G; Tack I; Unwin R; Vargas-Poussou R; Staub O; Grimm R; Welling PA; Gamba G; Clauser E; Hadchouel J; Jeunemaitre X
    J Clin Invest; 2020 Dec; 130(12):6379-6394. PubMed ID: 32790646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models.
    Liu Z; Xie J; Wu T; Truong T; Auchus RJ; Huang CL
    Hum Mol Genet; 2011 Mar; 20(5):855-66. PubMed ID: 21131289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.
    McCormick JA; Yang CL; Zhang C; Davidge B; Blankenstein KI; Terker AS; Yarbrough B; Meermeier NP; Park HJ; McCully B; West M; Borschewski A; Himmerkus N; Bleich M; Bachmann S; Mutig K; Argaiz ER; Gamba G; Singer JD; Ellison DH
    J Clin Invest; 2014 Nov; 124(11):4723-36. PubMed ID: 25250572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPAK and WNK kinases: a new target for blood pressure treatment?
    Glover M; O'shaughnessy KM
    Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):16-22. PubMed ID: 21088576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the intricate regulatory network controlling the thiazide-sensitive NaCl cotransporter (NCC).
    Dimke H
    Pflugers Arch; 2011 Dec; 462(6):767-77. PubMed ID: 21927811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation regulates NCC stability and transporter activity in vivo.
    Yang SS; Fang YW; Tseng MH; Chu PY; Yu IS; Wu HC; Lin SW; Chau T; Uchida S; Sasaki S; Lin YF; Sytwu HK; Lin SH
    J Am Soc Nephrol; 2013 Oct; 24(10):1587-97. PubMed ID: 23833262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Δ403-459 mutation.
    Murthy M; Kurz T; O'Shaughnessy KM
    Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27378813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.